ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,231,000 | +37.1% | 7,154 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $898,000 | -7.4% | 7,154 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $970,000 | +6.0% | 7,154 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $915,000 | +13.7% | 7,154 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $805,000 | +18.0% | 7,154 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $682,000 | +6.1% | 7,154 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $643,000 | +273.8% | 7,154 | +120.4% | 0.00% | +300.0% |
| Q4 2019 | $172,000 | +34.4% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $128,000 | -3.8% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $133,000 | -11.9% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $151,000 | +7.1% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $141,000 | -24.2% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $186,000 | +18.5% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $157,000 | +23.6% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $127,000 | -8.0% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $138,000 | – | 3,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |